Govt Job: Walk in interview for Pharmacist at PGIMER

The PGIMER owes its inception to the vision of late Sardar Partap Singh Kairon, the then Chief Minister of Punjab and the distinguished medical educationists of the then combined state of Punjab, supported by the first Prime Minister of India Pt. Jawahar Lal Nehru who considered the institutions of scientific knowledge as temples of learning and the places of pilgrimage.

Post : Pharmacist

Project Title : A PHASE 2/3, OBSERVER-BLIND, RANDOMIZED, CONTROLLED STUDY TO DETERMINE THE SAFETY AND IMMUNOGENICITY OF COVOVAX [SARS-CoV-2 RECOMBINANT SPIKE PROTEIN NANOPARTICLE VACCINE (SARS- CoV-2 rS) WITH MATRJX-M1 ™ ADJUVANT| IN INDIAN ADULTS AGED > 18 YEARS AND CHILDREN AGED 2 TO 17 YEARS

Qualification : Essential B.Pharma / Diploma in pharmacy from a recognized institution / board, should be a registered pharmacist under the pharmacy act 1948 – Minimum 1 year of experience in dispensing and /or storage and dispensing of drugs in a reputed hospital or institution or in a drug stores of a pharmaceutical concern / Clinical research experience.

Tenure : 3 months

Salary : 33,300/-

Date of Interview : 03rd  September,2021 (Friday)

Time of Interview : 03:00 pm

Selection Process :  An online interview will be conducted on 03ri1 September 2021 at 3:00 PM via zoom/Google meet. In view of C-19, no face to face Interview will be conducted.

How to apply : Interested candidate should email their applications along with their curriculum vitae (softcopy of resume) with supporting documents address to Dr, Madhu Gupta, Professor on email ID : covovax2021@gmail.com

Last date: before 05:00 PM dated 31/08/2021. No applications will be entertained after 05:00 PM on 31/08/2021

Related Posts

Dr Reddy’s delays semaglutide supplies due to API issue

MUMBAI: Dr Reddy’s Laboratories’ plans to capitalize on the early generic semaglutide market have hit a setback after manufacturing issues delayed supplies of the blockbuster diabetes and weight-loss drug, forcing…

India Tightens Rules On Alcohol-Containing Medicines

New rules on alcohol in medicine: The Centre has brought oral medicines containing more than 12% ethyl alcohol and sold in bottles larger than 30 ml under Schedule H1 In…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Dr Reddy’s delays semaglutide supplies due to API issue

Dr Reddy’s delays semaglutide supplies due to API issue

India Tightens Rules On Alcohol-Containing Medicines

India Tightens Rules On Alcohol-Containing Medicines

One more held in spurious plasma racket; police say he supplied 12 boxes

One more held in spurious plasma racket; police say he supplied 12 boxes

Wegovy, Ozempic regain weight as Indian generics fall behind

Wegovy, Ozempic regain weight as Indian generics fall behind

Drug regulator orders fresh safety labels for five common antimicrobials

Drug regulator orders fresh safety labels for five common antimicrobials

Rajasthan recalls labour-inducing drug after quality test failure

Rajasthan recalls labour-inducing drug after quality test failure